RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X
Viral disease is one of the greatest burdens for human health worldwide, with an urgent need for efficacious antiviral strategies. While antiviral drugs are available, in many cases, they are prone to the development of drug resistance. A way to overcome drug resistance associated with common antivi...
Main Authors: | Sundy N. Y. Yang, Sarah C. Atkinson, Michelle D. Audsley, Steven M. Heaton, David A. Jans, Natalie A. Borg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/1/170 |
Similar Items
-
TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity
by: Sarah C. Atkinson, et al.
Published: (2021-08-01) -
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
by: Massimiliano Secchi, et al.
Published: (2022-08-01) -
RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
by: Farhad Vesuna, et al.
Published: (2022-08-01) -
DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy
by: Lu Zhang, et al.
Published: (2021-06-01) -
The human DEAD-box helicase DDX3X as a regulator of mRNA translation
by: Cathal S. Ryan, et al.
Published: (2022-10-01)